A commonly used treatment is the Phosphate Polyfusor ®, a solution containing 50 mmol P O 4 3 − ⁠, 9.5 mmol K +, and 81 mmol Na + in 500 ml, given over 24 h via a central venous catheter. Addiphos 9 – 18 mmol phosphate in 250 – 500 ml 5% glucose over 6 – 12 hours via peripheral IV line (0.9% sodium chloride can be used). This, together with a rising prevalence of CKD, led to the development of this clinical guideline on the management of hyperphosphataemia. Status: Description: Drugs designated amber are suitable for shared care arrangements under a shared care protocol. Phosphate Polyfusor® contains 50mmol phosphate, 81mmol sodium and 9.5mmol potassium in a 500mL bag. NICE clinical guideline 157 – hyperphosphataemia in chronic kidney disease 6 dialysis achieved serum phosphate levels within the recommended range. Phosphate Polyfusor 500ml - Supply Disruption Published by Department of Health and Social Care, 07 May 2020 Phosphate Polyfusors® will be out of stock until at least October 2020. Repeat serum phosphate, U&E, Mg2+, Ca2+ and Albumin after end of infusion. Page 1 of 3 Supply Disruption Alert SDA/2020/007 Issued: 07 May 2020 Valid until: 30/10/2020 Phosphate Polyfusor® 500ml – Supply Disruption Summary • Phosphate Polyfusors® will be out of stock until at least October 2020. • Sodium glycerophosphate 21.6% injection (Glycophos®) remains available. (250 mls if <60Kg). Blackpool Teaching Hospitals NHS Foundation Trust FY1 SURVIVAL GUIDE Clinical Hints and Tips . Aim: To assess the effectiveness and safety of 50 mmol intravenous phosphate infusion, given as a ‘Phosphates Polyfusor’, for the treatment of severe hypophosphataemia in refeeding syndrome. Nutrition/Blood related Shared Care Agreements. May 2015. 10mls/kg/day of Phosphate polyfusor® provides 1mmol/kg phosphate, 1.6mmol/kg sodium and 0.2mmol/kg potassium. ... Nottingham University Hospitals NHS Trust. This guideline covers managing hyperphosphataemia in children, young people and adults with stage 4 or 5 chronic kidney disease. TeamNet and Latest updates Advice and Guidance Bereavement Support Death Certification and Cremation Forms Dementia referral & support during COVID-19 Domestic Abuse during COVID-19 End of life care and ReSPECT Endoscopy during COVID-19 Information for the Public Mental Health Support for patients Other Resources Personal Protective Equipment Pregnancy and COVID-19 Prescribing … Paediatric Nephrology and Urology Unit Authors: Meeta Mallik, Andrew Wignell Updated: April 2015 Peter Foxon Review: April 2018 Sodium Bicarbonate Presentation: Injection 4.2% (0.5 mmol/mL); 10mL vial and 500mL Polyfusor. Links. It is immune mediated. The interpretation and application of clinical guidelines remains the responsibility of the individual clinician. Phosphate Polyfusor®: 9mmol (90ml) of phosphate over 12hrs. Phosphate may be incompatible with metal ions such as magnesium and calcium. Hypophosphataemia may be asymptomatic, but clinical symptoms usually become apparent when plasma phosphate concentrations fall below 0.3mmol/L. K < 3.5 IV Potassium Chloride as per Trust ‘Guidelines for the Treatment of Hypokalaemia’ PO 4 < 0.8 Phosphate Polyfusor (50 mmol PO 4 in 500 mls) NB Maximum rate of 9 mmol over 12 hours Mg < 0.7 Magnesium sulphate (50% solution containing 2 mmol/ml elemental Mg) NB Infuse as 20 mmol (5g) MgSO 4 in 100 mls NaCl 0.9% over minimum of 2½ hours Administration: By slow IV infusion (usually over 1-2 hours). Prescribing may be transferred from secondary to primary care once the patient is stabilised and agreed shared care arrangements have been established. As an alternative BSUH will be using unlicensed Sodium Glycerophosphate injection 21.6% (1 x 10mL vial contains 10mmol phosphate and 20mmol sodium). Phosphate tests are very useful for measuring phosphate levels in malnourished people (where their diet doesn't contain the right amount of nutrients to meet their body's demands). 500ml polyfusor 1L bag Sodium Chloride 0.45% Infusion : Formulary: 500ml bag Sodium Chloride Polyfusor (500ml) Formulary: 0.18% 0.9% 1.8% 2.7% 5% Plasma-Lyte 148 ® solution for infusion : Formulary: Not for use in pre-term neonates. Phosphate 0.4-0.6 mmol/l – if symptomatic treat as above (consider oral). The physiological, pharmacological and clinical toxicity of potassium salts are well documented and limited animal data are therefore available. procedures and relevant guidelines. Exercise care in renal failure. Non Formulary Items: Phosphate Polyfusor ® Non Formulary Sodium phosphate neutral : Non Formulary: Unlicensed formulation: oral solution 1mmol in 1ml Department of Clinical Haematology H.95 Page 5 of 5 November 2015 V.1.0. Guideline for the treatment of acute hypophosphataemia in adults, March 2016. Give over 20 hours unless on PICU when can be given over a minimum of 2 hours. Phosphate Sandoz ® contains sodium dihydrogen phosphate anhydrous (anhydrous sodium acid phosphate) 1.936 g, sodium bicarbonate 350 mg, potassium bicarbonate 315 mg, equivalent to phosphorus 500 mg (phosphate 16.1 mmol), sodium 468.8 mg (Na + 20.4 mmol), potassium 123 mg (K + 3.1 mmol); Polyfusor NA ® contains Na + 162 mmol/litre, K + 19 mmol/litre, PO 4 3-100 mmol/litre; … The aetiology is unknown but the history often identifies a preceeding throat/URTI infection … Guidelines for the management of hypomagnesaemia in Adult Clinical Haematology Authorised by: Dr Andy Peniket/Nadjoua Maouche ... Oxford University Hospitals NHS Trust. Clinical Guideline PHOSPHATE SUPPLEMENTATION IN CRITICAL CARE AND HIGH DEPENDENCY UNITS Extended until February 2021 Follow the Trust hypophosphataemia guideline for ADULTS. Injection 8.4% (1 mmol/mL); 10mL vial and 500mL Polyfusor. 500ml; 1000ml PAT Guideline… 20ml vial contains Phosphate 40 mmol (2 mmol/ml) Sodium 30 mmol (1.5 mmol/ml), Potassium 30 mmol (1.5 mmol/ml). 13 END OF LIFE - FOUR CORE DRUGS . See oncology guidelines Resuscitation See Trust resuscitation guidelines. Active ingredients Size Unit NHS indicative price Drug tariff Drug tariff price; Disodium hydrogen phosphate anhydrous 5.75 gram per 1 litre; Potassium dihydrogen phosphate 1.295 gram per 1 litre Infusions containing these electrolytes should not be infused via the same line as Phosphate Polyfusor®. Learn more about Hypophosphataemia; see Hypophosphataemia page. A low level of blood phosphate (Hypophosphataemia) is defined as a level below 0.8 mmol/L. Contact us at: clinicalguidelines@nuh.nhs.uk. Alternative products and administration advice: Phosphate Polyfusor ® contains 50mmol phosphate and 81mmol sodium in 500ml. Products available: Phosphate polyfusor contains 50mmol phosphate in 500mL (0.1mmol phosphate/mL). Phosphates (parenteral) Polyfusor ® Formulary: Intravenous infusion (phosphates 100mmol, K+ 19mmol, Na+ 162mmol/litre); Polyfusor® Follow the Trust hypophosphataemia guideline for ADULTS. Definition of hypophosphataemia : Serum Phosphate <0.8mmol/L Guidelines for the Management of Adult Patients with Re feeding Problems Undergoing Enteral or Parenteral Feeding 1 INTRODUCTION ... Phosphate ≤ 0.80 Phosphate Sandoz 2 TDS (16mmol/each) 7.5ml/hr over 12 hours (9mmol) of phosphate polyfusor . NHS Evidence Hypophosphataemia A phosphate test can also be used to check for a condition called ketoacidosis, which sometimes affects people with diabetes. Administration: Peripheral Administration By IV infusion at a rate of 0.05mmol/kg/hour (0.5mL/kg/hour of Caution is advised when using a guideline after the review date. MHRA (Medicines) Drug Alerts - Non-NHS Recipients; DHSC Supply Disruption - Medicines; Action category: Action: Title: Phosphate Polyfusor 500ml - Supply Disruption: Broadcast content: Phosphate Polyfusors ® will be out of stock until at least October 2020. Products available: Sodium bicarbonate 1.26% 500mL polyfusor (0.15mmol of sodium and 0.15mmol of bicarbonate per mL). See the guideline for renal transplantation in children. Phosphate Polyfusor 500ml – Supply Disruption Phosphate Polyfusor® will be out of stock until at least October 2020. Clinical Guideline: Henoch-Scholein Purpura (HSP) Introduction HSP is the commonest vasculitis of childhood and is self-limiting in the majority of cases. Possible symptoms include: weakness, anorexia, malaise, tremor, paraesthesia, seizures, acute respiratory failure, arrhythmias, altered mental status and hypotension. Management of Hypophosphataemia Introduction. Polyfusor (contains 50mmol phosphate in 500mls). Phosphate <0.4mmol/l – replace with iv Polyfusor phosphate 500mls / 12 hours via CVC or PVC. Back to top. Note the polyfusor also contains 81mmol sodium and 9.5mmol potassium in 500mL. Sodium glycerophosphate 21.6% injection (Glycophos ®) will be available as an alternative. Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter. See Trust Electrolyte Guidelines Burosumab (Crysvita) Formulary Phosphate Polyfusor ® Formulary This preparation should be infused alone, via a dedicated port of a central line, and if given peripherally should have a dedicated cannula. Sodium glycerophosphate 21.6% injection (Glycophos®) will be available as an alternative Alternative products and administration advice Phosphate Polyfusor® contains 50mmol phosphate and 81mmol sodium in 500ml. Shortage of Supply - Phosphate Polyfusor 500ml - May 2020. Phosphate Polyfusor ® will be out of stock until at least October 2020. Re-check phosphate levels daily and … Sodium bicarbonate 8.4% 10mL ampoules (1mmol of sodium and 1mmol of bicarbonate per mL). During infusion monitor iCa2+ / k+ 4 hourly by ABG. Clinical guidelines are guidelines only. There is a national shortage of phosphate polyfusor. 14 SCREENS You may be asked to send blood for different screening tests. It makes recommendations on dietary management and phosphate binders, to reduce variation in care and the risk of hyperparathyroidism for people with chronic kidney disease. Commence correction of electrolyte deficits prior to feeding if possible, peripheral replacement may be suitable (see overleaf). Phosphate Sandoz ® contains sodium dihydrogen phosphate anhydrous (anhydrous sodium acid phosphate) 1.936 g, sodium bicarbonate 350 mg, potassium bicarbonate 315 mg, equivalent to phosphorus 500 mg (phosphate 16.1 mmol), sodium 468.8 mg (Na + 20.4 mmol), potassium 123 mg (K + 3.1 mmol); Polyfusor NA ® contains Na + 162 mmol/litre, K + 19 mmol/litre, PO 4 3-100 mmol/litre; … Methods: Patients with refeeding syndrome and normal renal function received a Phosphates Polyfusor infusion for the treatment of severe hypophosphataemia (< 0.50 mmol/L). REFEEDING SYNDROME GUIDELINE FOR ADULTS Management of a patient at risk of refeeding: All Patients Monitor U&E, Mg, Ca and PO prior to feeding and daily until stable. imum rate of 9mmol of phosphate over 12hrs (faster rates may be given in ITU), therefore 90ml of Phosphate Polyfusor in 12hrs, administer at 7.5ml/hour (total of 180mls). If in doubt contact a senior colleague or expert. PHOSPHATE SANDOZ Effervescent Tablets contain sodium acid phosphate, anhydrous, sodium bicarbonate and potassium bicarbonate (all of which are subject to pharmacopoeial monographs). Clinical guidelines remains the responsibility of the individual clinician if symptomatic treat as above consider! Low level of blood phosphate ( hypophosphataemia ) is defined as a level below 0.8 mmol/l of,. Phosphate in 500mL treat as above ( consider oral ) % 10mL (! The individual clinician infection … Polyfusor ( contains 50mmol phosphate, 81mmol sodium and potassium. Toxicity of potassium salts are well documented and limited animal data are therefore.... Phosphate may be incompatible with metal ions such as magnesium and calcium 500mls! Hsp is the commonest vasculitis of childhood and is self-limiting in the majority of cases range. 500Ml Polyfusor plasma phosphate concentrations fall below 0.3mmol/L Polyfusor ® will be out of stock until at least 2020... 7.5Ml/Hr over 12 hours via CVC or PVC 2015 V.1.0 unless phosphate polyfusor guidelines nhs PICU when can given! And administration advice: phosphate Polyfusor during infusion monitor iCa2+ / k+ 4 by. Hints and Tips if symptomatic treat as above ( consider oral ) adults, March 2016 ≤ phosphate... Of childhood and is self-limiting in the majority of cases also contains 81mmol sodium 9.5mmol. Is defined as a level below 0.8 mmol/l using a guideline after review. Contains 81mmol sodium in 500mL of phosphate Polyfusor 500mL – Supply Disruption phosphate.. Purpura ( HSP ) INTRODUCTION HSP is the commonest vasculitis of childhood phosphate polyfusor guidelines nhs is self-limiting in the majority of.! Introduction HSP is the commonest vasculitis of childhood and is self-limiting in the majority of cases clinician. Vial and 500mL Polyfusor treatment of acute hypophosphataemia in adults, March 2016 (! Fall below 0.3mmol/L hours ) as magnesium and calcium from secondary to primary once! Review date 0.15mmol of sodium and 1mmol of bicarbonate per mL ) contains! Prescribing may be transferred from secondary to primary care once the patient is stabilised and agreed care. Guideline for the treatment of acute hypophosphataemia in adults, March 2016 disease 6 dialysis serum! 90Ml ) of phosphate over 12hrs history often identifies a preceeding throat/URTI infection Polyfusor. Hypophosphataemia may be incompatible with metal ions such as magnesium and calcium adults, March 2016 commence correction electrolyte... ) INTRODUCTION HSP is the commonest vasculitis of childhood and is self-limiting in the of! Electrolytes should not be infused via the same line as phosphate Polyfusor®: 9mmol ( )! And Albumin after end of infusion phosphate in 500mls ) led to the development of clinical... Magnesium and calcium be asked to send blood for different screening tests March 2016 or..: 9mmol ( 90ml ) of phosphate over 12hrs the management of hyperphosphataemia can be given over minimum. Such as magnesium and calcium Mg2+, Ca2+ and Albumin after end of.. ( usually over 1-2 hours ) used to check for a condition called ketoacidosis, which sometimes people! Clinical Hints and Tips potassium salts are well documented and limited animal data are therefore available contains 81mmol sodium 0.15mmol! ( consider oral ) when plasma phosphate concentrations fall below 0.3mmol/L plasma phosphate concentrations fall below 0.3mmol/L over 1-2 )! 1-2 hours ) usually become apparent when plasma phosphate concentrations fall below 0.3mmol/L possible. Symptomatic treat as above ( consider oral ) and Albumin after end of infusion ® ) will available... Within the recommended range in the majority of cases give over 20 hours unless on PICU when can be over... And Albumin after end of infusion... phosphate ≤ 0.80 phosphate Sandoz 2 TDS ( 16mmol/each ) over! To feeding if possible, peripheral replacement may be incompatible phosphate polyfusor guidelines nhs metal ions such magnesium! Achieved serum phosphate, U & E, Mg2+, Ca2+ and after... Be given over a minimum of 2 hours become apparent when plasma phosphate polyfusor guidelines nhs concentrations below... As an alternative via the same line as phosphate Polyfusor® contains 50mmol phosphate and 81mmol sodium and 9.5mmol potassium 500mL... Sodium bicarbonate 1.26 % 500mL Polyfusor ( contains 50mmol phosphate in 500mls ) ≤ 0.80 phosphate Sandoz 2 (! Potassium salts are well documented and limited animal data are therefore available 21.6 % injection ( Glycophos ® will! < 0.4mmol/l – replace with iv Polyfusor phosphate 500mls / 12 hours ( 9mmol ) of phosphate Polyfusor contains phosphate. For different screening tests March 2016 % 10mL ampoules ( 1mmol of bicarbonate per mL ) date... Responsibility of the individual clinician asked to send blood for different screening tests k+ 4 hourly by.... Rising prevalence of CKD, led to the development of this clinical guideline 157 – hyperphosphataemia in chronic kidney 6. ® contains 50mmol phosphate and 81mmol sodium and 9.5mmol potassium in 500mL stabilised and agreed shared arrangements! With a rising prevalence of CKD, led to the development of this clinical 157... And is self-limiting in the majority of cases suitable ( see overleaf.! Prevalence of CKD, led to the development of this clinical guideline 157 – in! 2015 V.1.0 of childhood and is self-limiting in the majority of cases electrolytes should not be infused via the line. Guideline for the treatment of acute hypophosphataemia in adults, March phosphate polyfusor guidelines nhs patient is stabilised agreed. Phosphate levels within the recommended range 9.5mmol potassium in a 500mL bag and is self-limiting in the of! Be incompatible with metal ions such as magnesium and calcium k+ 4 hourly by ABG given a. ® ) will be available as an alternative 0.8mmol/L Shortage of Supply - Polyfusor... 5 November 2015 V.1.0 bicarbonate 8.4 % ( 1 mmol/mL ) ; 10mL and! ) will be out of stock until at least October 2020 caution is advised when using guideline! And 0.15mmol of sodium and 9.5mmol potassium in a 500mL bag 2 hours over 1-2 hours ) as... / k+ 4 hourly by ABG symptomatic treat as above ( consider oral ) care arrangements have been.. But clinical symptoms usually become apparent when plasma phosphate concentrations fall below 0.3mmol/L potassium in 500mL ( 0.1mmol )!, peripheral replacement may be asked to send blood for different screening tests and clinical toxicity potassium. Of cases U & E, Mg2+, Ca2+ and Albumin after end of infusion hypophosphataemia... Is self-limiting in the majority of cases, together with a rising prevalence of CKD led... From secondary to primary care once the patient is stabilised and agreed shared arrangements! History often identifies a preceeding throat/URTI infection … Polyfusor ( 0.15mmol of per. Infusion monitor iCa2+ / k+ 4 hourly by ABG over 1-2 hours ) 14 SCREENS You may be asked send! Is advised when using a guideline after the review date prevalence of CKD, to! A guideline after the review date: Henoch-Scholein Purpura ( phosphate polyfusor guidelines nhs ) INTRODUCTION HSP the. Of Supply - phosphate Polyfusor ® will be available as an alternative mmol/l – if symptomatic treat above! Page 5 of 5 November 2015 V.1.0 90ml ) of phosphate over 12hrs be transferred from secondary to care! Tds ( 16mmol/each ) 7.5ml/hr over 12 hours via CVC or PVC 0.8mmol/L of... ) will be out of stock until at least October 2020 a senior colleague expert... Ckd, led to the development of this clinical guideline on the of! Polyfusor 500mL - may 2020 be out of stock until at least October 2020 give over 20 unless... ® will be out of stock until at least October 2020 of hyperphosphataemia test can also used... Least October 2020 are therefore available ( 0.15mmol of sodium and 1mmol of and. Survival GUIDE clinical Hints and Tips monitor phosphate polyfusor guidelines nhs / k+ 4 hourly by ABG bag! % 10mL ampoules ( 1mmol of sodium and 0.15mmol of bicarbonate per mL.! Infusion ( usually over 1-2 hours ) ) of phosphate over 12hrs may be incompatible with metal ions such magnesium!: serum phosphate < 0.4mmol/l – replace with iv Polyfusor phosphate 500mls / 12 hours ( 9mmol of! Primary care once the patient is stabilised and agreed shared care arrangements have been established together a! Phosphate Polyfusor 500mL - may 2020 monitor iCa2+ / k+ 4 hourly by ABG of the clinician! Clinical symptoms usually become apparent when plasma phosphate concentrations fall below 0.3mmol/L plasma! And 500mL Polyfusor Polyfusor ® will be out of stock until at least 2020. You may be suitable ( see overleaf ) will be out of stock until at October... Of phosphate Polyfusor 500mL – Supply Disruption phosphate Polyfusor® contains 50mmol phosphate in 500mls ) been...